Stay updated on PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.

Latest updates to the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor site release. The change represents a routine maintenance update to the page template and underlying platform without altering study information.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe page shows Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor system or template update without changes to study data.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a deployed update to the site's study detail pages. This reflects a backend or frontend update rather than changes to the study data.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing Revision: v3.6.2. This appears to be a minor site/format update and does not modify the study data or trial information.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page footer revision was updated from v3.6.0 to v3.6.2, reflecting a small change to the page’s versioning.SummaryDifference0.1%

- Check95 days agoChange DetectedNew help and navigation sections were added to the study record (How to Read a Study Record, Common Questions, How to Join a Study) and the page revision was updated to v3.6.0; the Intervention/Treatment heading was standardized by removing the old Interventions / Treatment label and the v3.5.5 revision mention.SummaryDifference0.6%

Stay in the know with updates to PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.